Second life science startup inks new lease at 500 White Plains Rd.

TARRYTOWN, C.T., May 9, 2025 – JLL announced today it has arranged a new lease for digital chemical manufacturing platform DigiChem Corporation at 500 White Plain’s Rd. in Tarrytown, the only turnkey lab facility available in the Westchester market.

DigiChem is the latest startup to emerge from BioInc@NYMC, the biotechnology incubator on the Valhalla campus of New York Medical College. The company signed a five-year lease for 3,035 square feet of lab space on the 5th floor of 500 White Plains Rd., a 155,987-square-foot Class A office and laboratory building owned by Northpath Investments.

This is the second BioInc@NYMC startup to open its first permanent location at 500 White Plains Rd. Sapience Therapeutics, a clinical-stage biotechnology company, leased 8,352 square feet of second floor lab space at the property in 2022.

Northpath Investments acquired 500 & 540 White Plains Rd. in 2020 and leased the majority of the research and development facility at building 500 back to the seller, chemical giant BASF Corporation.

Gershon Alexander, of Northpath Investments, said, “We are thrilled to welcome DigiChem to our roster of leading tenants. 500 White Plains Rd. is uniquely positioned to accommodate the region’s growing life science sector with state-of-the-art, turnkey lab space in an ideal location.”

A JLL team led by Executive Vice President Ian Ceppos and Senior Vice President John Cahill serves as the exclusive leasing agent for the available space across the entire 155,000-square-foot, hub located within the Tarrytown Corporate Center in Westchester County. DigiChem was represented by Michael Litsky of Rakow Commercial Realty Group.

Said Ceppos, “Westchester’s life science incubators are playing a critical role in the development of new medical therapies and devices and in the creation of dynamic new companies. 500 White Plains Rd. provides superior, cost-efficient lab and office space to support the business goals of young companies.”

JLL is currently marketing select availabilities across the property, ranging from 3,125 – 16,404 square feet of R&D/Laboratory space and 5,375 square feet of adjacent office space. A contiguous 50,000 square feet of Lab/R&D space could also be delivered as a build-to-suit opportunity for a larger tenant.

Tarrytown Corporate Center is a 16-acre site with direct access to Interstates 87 and 287, the Mario M. Cuomo Bridge and the Tarrytown Train Station, providing tremendous connectivity throughout the Tri-state region. In addition, the immediate area surrounding the properties are home to a host of retail, entertainment and hospitality amenities.

JLL is a leader in the New York tri-state commercial real estate market, with more than 4,800 of the most recognized industry experts offering brokerage, capital markets, property/facilities management, consulting, and project and development services.

For more news, videos and research resources, please visit JLL’s newsroom.

Northpath Investments is a privately held real estate investment firm headquartered in New York City. Northpath is focused on the acquisition, development, redevelopment and management of retail, industrial and office properties in the Northeast and Mid-Atlantic. Northpath has an excellent track record in the ownership and management of real estate assets and seeks to create value for investors, partners, and the communities in which they work and live. For more information visit www.northpathinvestments.com